Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GHF-ACL: A novel contrastive learning framework with multi-order graph structures for herb-disease association prediction.

PLoS computational biology·2026
Same author

CanLRHI: a multimodal pretraining model for cell death analysis in cancer pathology based on long-text representation and high-resolution images.

Briefings in bioinformatics·2026
Same author

TCRBinder: Unified pre-trained language model with paired-chain synergy for predicting T-cell receptor binding specificity.

PLoS computational biology·2026
Same author

GMHAN: a heterogeneous graph attention framework for prioritizing coding and non-coding driver genes.

Bioinformatics (Oxford, England)·2026
Same author

SINTER3D: continuous 3D reconstruction of spatial transcriptomics via implicit neural representations.

Genome biology·2026
Same author

spAttClu: a spatial domain clustering model leveraging spatially weighted graph attention and contrastive learning.

Bioinformatics (Oxford, England)·2026
Same journal

RETRACTED: Kim et al. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Regulating the Visceral Adipose-Tissue Function. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 846.

International journal of molecular sciences·2026
Same journal

Correction: Mahmud et al. Thymoquinone Attenuates NF-κβ Signalling Activation in Retinal Pigment Epithelium Cells Under AMD-Mimicking Conditions. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 11473.

International journal of molecular sciences·2026
Same journal

Correction: Borovikov et al. The Twisting and Untwisting of Actin and Tropomyosin Filaments Are Involved in the Molecular Mechanisms of Muscle Contraction, and Their Disruption Can Result in Muscle Disorders. <i>Int. J. Mol. Sci</i>. 2025, <i>26</i>, 6705.

International journal of molecular sciences·2026
Same journal

Correction: Molagoda et al. Flavonoid Glycosides from <i>Ziziphus jujuba</i> var. <i>inermis</i> (Bunge) Rehder Seeds Inhibit α-Melanocyte-Stimulating Hormone-Mediated Melanogenesis. <i>Int. J. Mol. Sci.</i> 2021, <i>22</i>, 7701.

International journal of molecular sciences·2026
Same journal

Correction: Guo et al. Integrated Transcriptomic and Metabolomic Analysis Reveals the Molecular Regulatory Mechanism of Flavonoid Biosynthesis in Maize Roots Under Lead Stress. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 6050.

International journal of molecular sciences·2026
Same journal

Correction: Chang et al. Improvement of Carbon Tetrachloride-Induced Acute Hepatic Failure by Transplantation of Induced Pluripotent Stem Cells Without Reprogramming Factor c-Myc. <i>Int. J. Mol. Sci.</i> 2012, <i>13</i>, 3598-3617.

International journal of molecular sciences·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

MOTCS: A Cancer Subtype Classification and Key Biomarker Recognition Model Based on Multi-Omics Data Integration of

Ping Meng1, Guohua Wang1, Tianjiao Zhang2

  • 1Faculty of Computing, Harbin Institute of Technology, Harbin 150001, China.

International Journal of Molecular Sciences
|May 27, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces MOTCS, a novel cancer subtype classification model that integrates multi-omics data and driver genes. MOTCS enhances tumor classification accuracy by learning feature embeddings from driver and non-driver genes.

Keywords:
cancer subtypedriver genemulti-omicstransformer

Related Experiment Videos

Last Updated: May 28, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Cancer exhibits high heterogeneity, necessitating personalized treatment strategies.
  • Multi-omics data (genome, transcriptome, epigenome) integration offers a comprehensive view of tumor molecular features.
  • Driver genes are crucial for tumorigenesis and improving model interpretability when combined with multi-omics data.

Purpose of the Study:

  • To develop an advanced computational model for precise cancer subtype classification.
  • To investigate the impact of integrating driver gene information with multi-omics data for improved classification.
  • To enhance the interpretability of cancer subtype classification models.

Main Methods:

  • Feature extraction and selection for driver and non-driver genes across multiple omics datasets.
  • Utilizing transformer encoders for feature representation learning of both gene types.
  • Concatenating omics-specific feature embeddings and employing MLP classifiers.
  • Integrating cross-omics feature representations via view association discovery networks.

Main Results:

  • The proposed MOTCS model demonstrated superior performance across four independent cancer datasets compared to existing methods.
  • Incorporating driver gene features significantly improved the classification accuracy of MOTCS.
  • MOTCS effectively achieved precise cancer subtype classification by leveraging mined feature embeddings.

Conclusions:

  • MOTCS provides a robust framework for cancer subtype classification by integrating multi-omics data and driver gene information.
  • The model's performance highlights the importance of driver genes in understanding cancer complexity and heterogeneity.
  • This approach advances personalized medicine by enabling more accurate identification of cancer subtypes.